Here’s the break down:
A new type of flu drug that can stop resistant strains in their tracks shows promise, say US researchers. It permanently blocks a key enzyme on the surface of the flu virus, stopping it from spreading to other cells.
The World Health Organization estimates that influenza affects three to five million people every year.
Resistance to the existing flu drugs Relenza and Tamiflu is becoming an increasing problem, largely due to their overuse.
A team of researchers from Canada, the UK and Australia developed a compound that binds to an enzyme on the surface of the flu virus called neuraminidase. The new class of drugs – DFSAs – permanently bind to the enzyme, blocking its action and stopping it from spreading further, the journal Science reported.
Prof John Oxford, a virology expert at Queen Mary, University of London, said the work seemed to be a significant step forward. “It is always nice to have an extra drug in the medicine cupboard and it would be reassuring if in the near future we had a second line drug.”
Now we wait in a crouch position. It’s always easier for a disease to spread in times of over population. Perhaps the earth has had enough of our crap.